Skip to main content

Table 2 Clinical criteria for PTEN hamartoma tumor syndrome as suggested by Pilarski et al.[22]

From: Hamartomatous polyposis syndromes: A review

Major criteria

•

Breast cancer

•

Endometrial cancer (epithelial)

•

Thyroid cancer (follicular)

•

Gastrointestinal hamartomas (including ganglioneuromas, but excluding hyperplastic polyps; ≥3)

•

Lhermitte-Duclos disease (adult)

•

Macrocephaly (≥97 percentile: 58 cm for females, 60 cm for males)

•

Macular pigmentation of the glans penis

•

Multiple mucocutaneous lesions (any of the following)

 

o Multiple trichilemmomas (≥3, at least one biopsy proven)

o Acral keratoses (≥3 palmoplantar keratotic pits and/or acral hyperkeratotic papules)

o Mucocutaneous neuromas (≥3)

o Oral papillomas (particularly on tongue and gingiva), multiple (≥3) OR biopsy proven OR dermatologist diagnosed

Minor criteria

•

Autism spectrum disorder

•

Colon cancer

•

Esophageal glycogenic acanthosis (≥3)

•

Lipomas (≥3)

•

Mental retardation (ie, IQ ≤ 75)

•

Renal cell carcinoma

•

Testicular lipomatosis

•

Thyroid cancer (papillary or follicular variant of papillary)

•

Thyroid structural lesions (eg, adenoma, multinodular goiter)

•

Vascular anomalies (including multiple intracranial developmental venous anomalies)

Operational diagnosis in an individual (either of the following)

1. Three or more major criteria, but one must include macrocephaly, Lhermitte-Duclos disease, or gastrointestinal hamartomas; or

2. Two major and three minor criteria.

Operational diagnosis in a family where one individual meets revised PTEN hamartoma tumor syndrome clinical diagnostic criteria or has a PTEN mutation:

1. Any two major criteria with or without minor criteria; or

2. One major and two minor criteria; or

3. Three minor criteria.